Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. signed Share Transfer Agreement to acquire 6.88% stake in Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd. for CNY 160 million.

Thalys Medical Technology Group Corp, formerly Thalys Medical Technology Inc, is a China-based company principally engaged in the provision of intensified distribution business and simple sales business and the research, design, manufacture and distribution of independent in vitro diagnostic products. Its product type includes purchased reagents and consumables, self-produced reagents and consumables, as well as purchased equipment. The Company mainly operates its business in domestic markets, with Hubei, Hunan, Jiangsu, Henan and Shanghai province as its major markets.